Exact Mass: 273.0824

Exact Mass Matches: 273.0824

Found 12 metabolites which its exact mass value is equals to given mass value 273.0824, within given mass tolerance error 0.001 dalton. Try search metabolite list with more accurate mass tolerance error 0.0002 dalton.

Modafinil

2-((R)-(Diphenylmethyl)sulfinyl)acetamide

C15H15NO2S (273.0823)


Modafinil is a stimulant drug marketed as a wakefulness promoting agent and is one of the stimulants used in the treatment of narcolepsy. Narcolepsy is caused by dysfunction of a family of wakefulness-promoting and sleep-suppressing peptides, the orexins, whose neurons are activated by modafinil. The prexin neuron activation is associated with psychoactivation and euphoria. The exact mechanism of action is unclear, although in vitro studies have shown it to inhibit the reuptake of dopamine by binding to the dopamine reuptake pump, and lead to an increase in extracellular dopamine. Modafinil activates glutamatergic circuits while inhibiting GABA. N - Nervous system > N06 - Psychoanaleptics > N06B - Psychostimulants, agents used for adhd and nootropics > N06BA - Centrally acting sympathomimetics D002491 - Central Nervous System Agents > D000697 - Central Nervous System Stimulants > D064690 - Wakefulness-Promoting Agents D065693 - Cytochrome P-450 Enzyme Inducers > D065701 - Cytochrome P-450 CYP3A Inducers COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C78272 - Agent Affecting Nervous System > C47795 - CNS Stimulant Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   
   

provigil

modafinil

C15H15NO2S (273.0823)


N - Nervous system > N06 - Psychoanaleptics > N06B - Psychostimulants, agents used for adhd and nootropics > N06BA - Centrally acting sympathomimetics D002491 - Central Nervous System Agents > D000697 - Central Nervous System Stimulants > D064690 - Wakefulness-Promoting Agents D065693 - Cytochrome P-450 Enzyme Inducers > D065701 - Cytochrome P-450 CYP3A Inducers COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C78272 - Agent Affecting Nervous System > C47795 - CNS Stimulant Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   

2-(4-methylphenyl)sulfonyl-1,3-dihydroisoindole

2-(4-methylphenyl)sulfonyl-1,3-dihydroisoindole

C15H15NO2S (273.0823)


   
   

Ethyl morpholine-2-carboxylate 2,2,2-trifluoroacetate

Ethyl morpholine-2-carboxylate 2,2,2-trifluoroacetate

C9H14F3NO5 (273.0824)


   

armodafinil

armodafinil

C15H15NO2S (273.0823)


N - Nervous system > N06 - Psychoanaleptics > N06B - Psychostimulants, agents used for adhd and nootropics > N06BA - Centrally acting sympathomimetics D002491 - Central Nervous System Agents > D000697 - Central Nervous System Stimulants > D064690 - Wakefulness-Promoting Agents D065693 - Cytochrome P-450 Enzyme Inducers > D065701 - Cytochrome P-450 CYP3A Inducers C78272 - Agent Affecting Nervous System > C47795 - CNS Stimulant

   

4-METHYL-N-(4-METHYL-BENZYLIDENE)BENZENESULFONAMIDE

4-METHYL-N-(4-METHYL-BENZYLIDENE)BENZENESULFONAMIDE

C15H15NO2S (273.0823)


   

2-methoxy-N-[2-(methylthio)phenyl]benzamide

2-methoxy-N-[2-(methylthio)phenyl]benzamide

C15H15NO2S (273.0823)


   

N-(4-methoxyphenyl)-2-(methylthio)benzamide

N-(4-methoxyphenyl)-2-(methylthio)benzamide

C15H15NO2S (273.0823)


   

3-(1,3-Benzoxazol-2-ylsulanyl)-5,5-dimethylcyclohex-2-en-1-one

3-(1,3-Benzoxazol-2-ylsulanyl)-5,5-dimethylcyclohex-2-en-1-one

C15H15NO2S (273.0823)